Benny, O., Khan, A., James, A. R., Tan, J. K., Koprivec, I., Benedict, A., Urs, V., Grigoryan, V., Khachatryan, M., Ramkeelawon, D. D. S., Jbeili, A., Lapitan, P., Mukherjee, I., Khanna, D., Owoseni, Y., Maniam, A., Adomah, S., Ghose, A., Ayodele, O. (2026). Ethnicity-based comparative analysis of treatment endpoints of 30,000 HR+/HER2− metastatic breast cancer patients on CDK4/6 inhibitors (palbociclib/ribociclib/abemaciclib).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1085